Stockreport

Acer Therapeutics Reports Positive Results From Pivotal Clinical Trial of EDSIVO™ (celiprolol) for Treatment of Vascular Ehlers-Danlos Syndrome

Acer Therapeutics Inc.  (ACER) 
Last acer therapeutics inc. earnings: 3/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: acertx.com/investor-relations
PDF - Company intends to file NDA for EDSIVO™ in first half of 2018 - CAMBRIDGE, Mass., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc., (Nasdaq:ACER), a pharma [Read more]